When administering eye drops to a client with glaucoma, where should the eye drops be placed?

When administering eye drops to a client with glaucoma, where should the eye drops be placed?

• A. In the lower conjunctival sac.
• B. Near the opening of the lacrimal ducts.
• C. On the cornea.
• D. On the scleral surface.

Answer: (A)

Placing eye drops in the lower conjunctival sac is the preferred method for administering eye drops, especially for a client with glaucoma. The conjunctival sac is the space between the inner eyelid and the eyeball, which allows for the drops to be evenly distributed over the surface of the eye when the client blinks. This technique minimizes the risk of the drops dripping out of the eye and ensures that the medication has enough time to be absorbed effectively, which is particularly important in managing glaucoma as it often requires precise dosing for intraocular pressure reduction. This method also helps reduce systemic absorption of the medication, as placing drops closer to the lacrimal ducts or directly on the cornea can increase the risk of the medication entering the bloodstream. Additionally, placing the drops directly on the cornea or scleral surface may cause discomfort and interfere with vision, making the administration less effective and potentially leading to harm for the patient. Therefore, correctly administering the medication into the lower conjunctival sac is crucial for optimal therapeutic outcomes.

Placing eye drops in the lower conjunctival sac is the preferred method for administering eye drops, especially for a client with glaucoma. The conjunctival sac is the space between the inner eyelid and the eyeball, which allows for the drops to be evenly distributed over the surface of the eye when the client blinks. This technique minimizes the risk of the drops dripping out of the eye and ensures that the medication has enough time to be absorbed effectively, which is particularly important in managing glaucoma as it often requires precise dosing for intraocular pressure reduction.

This method also helps reduce systemic absorption of the medication, as placing drops closer to the lacrimal ducts or directly on the cornea can increase the risk of the medication entering the bloodstream. Additionally, placing the drops directly on the cornea or scleral surface may cause discomfort and interfere with vision, making the administration less effective and potentially leading to harm for the patient. Therefore, correctly administering the medication into the lower conjunctival sac is crucial for optimal therapeutic outcomes.